Atlas Trials

Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer

Clinical trial NCT00924352 · COMPLETED

Trial details

NCT number
NCT00924352
Sponsor
Accelerated Community Oncology Research Network
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2009-06-01
Primary completion
2013-10-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.